The Liquigas team has withdrawn Manuel Beltran from the Tour de France for taking EPO, the performance enhancing drug.
The move was prompted by an announcement that Beltran’s A sample from the first stage of the Tour tested positive.
The positive test was first reported by French daily L’Equipe on its website.